Is Macro Bank (BMA) Stock Outpacing Its Finance Peers This Year?

BMA

Investors focused on the Finance space have likely heard of Macro Bank (BMA - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.

Macro Bank is one of 856 individual stocks in the Finance sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BMA is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for BMA's full-year earnings has moved 26.87% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

According to our latest data, BMA has moved about 3.41% on a year-to-date basis. At the same time, Finance stocks have gained an average of 11.52%. This means that Macro Bank is performing better than its sector in terms of year-to-date returns.

Breaking things down more, BMA is a member of the Banks - Foreign industry, which includes 64 individual companies and currently sits at #190 in the Zacks Industry Rank. Stocks in this group have gained about 5.95% so far this year, so BMA is slightly underperforming its industry this group in terms of year-to-date returns.

Investors with an interest in Finance stocks should continue to track BMA. The stock will be looking to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>